Web31 ian. 2024 · Jasper Therapeutics, Inc. is a clinical-stage biotechnology company developing briquilimab, a monoclonal antibody targeting c-Kit (CD117) as a therapeutic … Web13 apr. 2024 · Furthermore, Jasper Therapeutics Inc. (JSPR)’s average true range (ATR) is 0.13. The company’s stock has been forecasted to trade at an average price of $6.21 …
Jasper Therapeutics, Inc. Common Stock (JSPR) - Nasdaq
Web6 apr. 2024 · Further, Jasper Therapeutics Inc. (JSPR) has a beta value of 0, and an average true range (ATR) of 0.14. Analysts have given the company’s stock an average 52-week price target of $6.21, forecast between a low of $4.00 and high of $8.00. Looking at the price targets, the low is -158.06% off current price level while to achieve the yearly ... Web10 apr. 2024 · Jasper Therapeutics, Inc. kondigde de benoeming aan van David Hinds tot Senior Vice President, Development Operations. De heer Hinds brengt meer dan 25 jaar ervaring mee in operaties en klinische... 13 april 2024 gi joe game switch
公告正文 _ 数据中心 _ 东方财富网
WebJasper Therapeutics, Inc. Common Stock (JSPR) Nasdaq Listed. CLOSED AT 4:00 PM ET ON Jul 05, 2024. DATA AS OF Jul 05, 2024 7:05 PM ET - AFTER HOURS. Add to Watchlist. Add to Portfolio. Web14 feb. 2024 · About Jasper Therapeutics, Inc. 2200 BRIDGE PARKWAY SUITE NO. 102, REDWOOD, California, 94065, United States +1 650 549-1400 … WebTodo sobre el precio de las acciones de Jasper Therapeutics en bolsa (NASDAQ:JSPR), con gráficos, análisis y más sobre la cotización de Jasper Therapeutics (Acciones JSPR). ftir predictor